Compare PSN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSN | ACHC |
|---|---|---|
| Founded | 1944 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 1.3B |
| IPO Year | 2019 | N/A |
| Metric | PSN | ACHC |
|---|---|---|
| Price | $61.58 | $14.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $84.64 | $24.00 |
| AVG Volume (30 Days) | 2.2M | ★ 3.5M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.02 | N/A |
| EPS | ★ 2.17 | 1.18 |
| Revenue | ★ $6,494,748,000.00 | $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $5.69 | $4.38 |
| P/E Ratio | $27.91 | ★ $12.24 |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $54.56 | $12.63 |
| 52 Week High | $97.91 | $47.08 |
| Indicator | PSN | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 27.86 | 36.65 |
| Support Level | $60.00 | $13.95 |
| Resistance Level | $62.21 | $14.94 |
| Average True Range (ATR) | 2.81 | 0.85 |
| MACD | -1.10 | 0.21 |
| Stochastic Oscillator | 6.42 | 42.12 |
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.